Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Biotech
Amgen-backed quantum computing firm plans IPO
A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public.
James Waldron
May 10, 2026 8:25am
Amgen abandons cancer, Sjögren’s drugs over weak ph.2 data
May 1, 2026 1:45am
FDA unveils plan for real-time review of clinical trial data
Apr 28, 2026 1:52pm
Helus CEO out after two months—Chutes & Ladders
Apr 24, 2026 8:30am
Boehringer, Amgen scrap immunology assets, citing low potential
Apr 14, 2026 4:00am
'Can it deliver?': Why Big Pharma has entered the quantum realm
Apr 10, 2026 7:20am
